THE ROLE OF MICROBIAL ENGRAFTMENT AND KEYSTONE SPECIES IN THE EFFICACY OF FAECAL MICROBIOTA TRANSPLANTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - A REVIEW OF RECENT STUDIES
DOI:
https://doi.org/10.31435/ijitss.1(49).2026.4881Keywords:
Faecal Microbiota Transplantation, Inflammatory Bowel Disease, Microbial Engraftment, Keystone Taxa, Donor Effect, Gut MicrobiomeAbstract
Background: Inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis, are chronic relapsing disorders in which alterations of the gut microbiota contribute to disease pathogenesis. Despite advances in pharmacological therapies, sustained remission remains difficult to achieve in many patients, prompting interest in microbiome-targeted interventions such as faecal microbiota transplantation.
Objectives: This study aimed to review evidence published between 2015 and 2025 on the efficacy of faecal microbiota transplantation in inflammatory bowel diseases, with emphasis on donor microbiota engraftment, keystone taxa, the donor effect, and differences between ulcerative colitis and Crohn’s disease.
Methods: A narrative–systematic review of clinical, metagenomic, and ecological studies addressing faecal microbiota transplantation in inflammatory bowel diseases was conducted using major biomedical databases.
Results: Clinical response following faecal microbiota transplantation was more consistently associated with stable and functional engraftment of donor-derived microbial strains than with restoration of microbial diversity alone. Evidence supporting this association was stronger in ulcerative colitis, whereas data in Crohn’s disease remained limited and largely observational. Variability in outcomes appeared to reflect interactions between donor and recipient microbiota.
Conclusions: Faecal microbiota transplantation represents a complex ecological intervention, the efficacy of which depends on engraftment stability, functional reconstruction of the gut microbiome, and recipient-specific ecological context.
References
Aldars-García, L., Chaparro, M., & Gisbert, J. P. (2021). Systematic review: The gut microbiome and its potential clinical application in inflammatory bowel disease. Microorganisms, 9(5), 977. https://doi.org/10.3390/microorganisms9050977
Bénard, M. V., de Goffau, M. C., Blonk, J., Hugenholtz, F., van Buuren, J., Paramsothy, S., Kaakoush, N. O., D’Haens, G. R. A. M., Borody, T. J., Kamm, M. A., & Ponsioen, C. Y. (2025). Gut microbiota features in relation to fecal microbiota transplantation outcome in ulcerative colitis: A systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 23(10), 1719–1736. https://doi.org/10.1016/j.cgh.2024.10.001
Bi, Y., Cheng, B., Zou, B., Liu, S., & Cui, Z. (2025). The current landscape of fecal microbiota transplantation in treating inflammatory bowel disease. Translational Gastroenterology and Hepatology, 10, 55. https://doi.org/10.21037/tgh-24-138
Caldeira, L. F., Borba, H. H., Tonin, F. S., Wiens, A., Fernandez-Llimos, F., & Pontarolo, R. (2020). Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis. PLOS ONE, 15(9), e0238910. https://doi.org/10.1371/journal.pone.0238910
Fanizzi, F., D’Amico, F., Zanotelli Bombassaro, I., Zilli, A., Furfaro, F., Parigi, T. L., Cicerone, C., Fiorino, G., Peyrin-Biroulet, L., Danese, S., & Allocca, M. (2024). The role of fecal microbiota transplantation in IBD. Microorganisms, 12(9), 1755. https://doi.org/10.3390/microorganisms12091755
Feng, J., Chen, Y., Liu, Y., Lin, L., Lin, X., Gong, W., Xia, R., He, J., Sheng, J., Cai, H., & Xiao, C. (2023). Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: A systematic review and meta-analysis. Scientific Reports, 13, Article 14494. https://doi.org/10.1038/s41598-023-41182-6
Franzosa, E. A., Sirota-Madi, A., Avila-Pacheco, J., Fornelos, N., Haiser, H. J., Reinker, S., Vatanen, T., Hall, A. B., Mallick, H., McIver, L. J., Sauk, J. S., Wilson, R. G., Stevens, B. W., Scott, J. M., Pierce, K., Deik, A. A., Bullock, K., Imhann, F., Porter, J. A., … Xavier, R. J. (2019). Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nature Microbiology, 4(2), 293–305. https://doi.org/10.1038/s41564-018-0306-4
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., Morgan, X. C., Kostic, A. D., Luo, C., González, A., McDonald, D., Haberman, Y., Walters, T., Baker, S., Rosh, J., Stephens, M., … Xavier, R. J. (2014). The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host & Microbe, 15(3), 382–392. https://doi.org/10.1016/j.chom.2014.02.005
Gogokhia, L., Tran, N., Grier, A., Nagayama, M., Xiang, G., Funez-dePagnier, G., Lavergne, A., Ericsson, C., Ben Maamar, S., Zhang, M., Battat, R., Scherl, E., Lukin, D. J., & Longman, R. S. (2025). Donor composition and fiber promote strain engraftment in a randomized controlled trial of fecal microbiota transplant for ulcerative colitis. Med, 6(9), 100707. https://doi.org/10.1016/j.medj.2025.100707
Halfvarson, J., Brislawn, C. J., Lamendella, R., Vázquez-Baeza, Y., Walters, W. A., Bramer, L. M., D’Amato, M., Bonfiglio, F., McDonald, D., Gonzalez, A., McClure, E. E., Dunklebarger, M. F., Knight, R., & Jansson, J. K. (2017). Dynamics of the human gut microbiome in inflammatory bowel disease. Nature Microbiology, 2, 17004. https://doi.org/10.1038/nmicrobiol.2017.4
Ianiro, G., Punčochář, M., Karcher, N., Porcari, S., Armanini, F., Asnicar, F., Beghini, F., Blanco-Míguez, A., Cumbo, F., Manghi, P., Pinto, F., Masucci, L., Quaranta, G., De Giorgi, S., Sciumè, G. D., Bibbò, S., Del Chierico, F., Putignani, L., Sanguinetti, M., Gasbarrini, A., … Segata, N. (2022). Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. Nature Medicine, 28(9), 1913–1923. https://doi.org/10.1038/s41591-022-01964-3
Imdad, A., Nicholson, M. R., Tanner-Smith, E. E., Zackular, J. P., Gomez-Duarte, O. G., Beaulieu, D. B., & Acra, S. (2018). Fecal transplantation for treatment of inflammatory bowel disease. The Cochrane Database of Systematic Reviews, 11(11), CD012774. https://doi.org/10.1002/14651858.CD012774.pub2
Imhann, F., Vich Vila, A., Bonder, M. J., Fu, J., Gevers, D., Visschedijk, M. C., Spekhorst, L. M., Alberts, R., Franke, L., van Dullemen, H. M., Ter Steege, R. W. F., Huttenhower, C., Dijkstra, G., Xavier, R. J., Festen, E. A. M., Wijmenga, C., Zhernakova, A., & Weersma, R. K. (2018). Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut, 67(1), 108–119. https://doi.org/10.1136/gutjnl-2016-312135
Ishikawa, D., Zhang, X., Nomura, K., & Nagahara, A. (2025). Fecal microbiota transplantation for inflammatory bowel disease: Where we stand and what is next. Inflammatory Intestinal Diseases, 10(1), 371–386. https://doi.org/10.1159/000549227
Kong, L., Lloyd-Price, J., Vatanen, T., Seksik, P., Beaugerie, L., Simon, T., Vlamakis, H., Sokol, H., & Xavier, R. J. (2020). Linking strain engraftment in fecal microbiota transplantation with maintenance of remission in Crohn’s disease. Gastroenterology, 159(6), 2193–2202.e5. https://doi.org/10.1053/j.gastro.2020.08.045
Lauridse, H., Mollerup, S., Jensen, B., Andersen, L., Nielsen, H., Helms, M., & Petersen, A. (2024). Fecal microbiota transplantation promotes disease remission in a patient with active Crohn’s disease: A case report. Medical Research Archives, 12(5). https://doi.org/10.18103/mra.v12i5.5462
Liu, H., Li, J., Yuan, J., Huang, J., & Xu, Y. (2023). Fecal microbiota transplantation as a therapy for treating ulcerative colitis: An overview of systematic reviews. BMC Microbiology, 23(1), 371. https://doi.org/10.1186/s12866-023-03107-1
Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., Casero, D., Courtney, H., Gonzalez, A., Graeber, T. G., Hall, A. B., Lake, K., Landers, C. J., Mallick, H., Plichta, D. R., Prasad, M., … Huttenhower, C. (2019). Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature, 569(7758), 655–662. https://doi.org/10.1038/s41586-019-1237-9
Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B., Bousvaros, A., Korzenik, J., Sands, B. E., Xavier, R. J., & Huttenhower, C. (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biology, 13(9), R79. https://doi.org/10.1186/gb-2012-13-9-r79
Ni, J., Wu, G. D., Albenberg, L., & Tomov, V. T. (2017). Gut microbiota and IBD: Causation or correlation? Nature Reviews Gastroenterology & Hepatology, 14(10), 573–584. https://doi.org/10.1038/nrgastro.2017.88
Nowak, E., Widłak, K., Pawłowski, P., Ziętara, K., Orzechowska, A., Kościołek, A., & Adamska-Kuźmicka, I. (2022). Fecal microbiota transplantation—analysis of scientific reports, the role of a nurse. Journal of Education, Health and Sport, 12(1), 160–171. https://doi.org/10.12775/JEHS.2022.12.01.013
Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., Xuan, W., Lin, E., Mitchell, H. M., & Borody, T. J. (2017). Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: A randomised placebo-controlled trial. Lancet, 389(10075), 1218–1228. https://doi.org/10.1016/S0140-6736(17)30182-4
Pascal, V., Pozuelo, M., Borruel, N., Casellas, F., Campos, D., Santiago, A., Martinez, X., Varela, E., Sarrabayrouse, G., Machiels, K., Vermeire, S., Sokol, H., Guarner, F., & Manichanh, C. (2017). A microbial signature for Crohn’s disease. Gut, 66(5), 813–822. https://doi.org/10.1136/gutjnl-2016-313235
Patryn, R., Kazmierczak-Wojtas, N., Bulas, L., Boretska, O., Szkultecka-Debek, M., Drozd, M., & Blicharski, T. (2024). Faecal microbiota transplantation associated adverse events. Current Issues in Pharmacy and Medical Sciences, 37(3), 171–178. https://doi.org/10.2478/cipms-2024-0028
Pinto, S., Šajbenová, D., Benincà, E., Nooij, S., Terveer, E. M., Keller, J. J., van der Meulen-de Jong, A. E., Bogaards, J. A., & Steyerberg, E. W. (2025). Dynamics of gut microbiota after fecal microbiota transplantation in ulcerative colitis: Success linked to control of Prevotellaceae. Journal of Crohn’s & Colitis, 19(2), jjae137. https://doi.org/10.1093/ecco-jcc/jjae137
Podlesny, D., Durdevic, M., Paramsothy, S., Kaakoush, N. O., Högenauer, C., Gorkiewicz, G., Walter, J., & Fricke, W. F. (2022). Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics. Cell Reports Medicine, 3(8), 100711. https://doi.org/10.1016/j.xcrm.2022.100711
Raich, S. S., Majzoub, M. E., Haifer, C., Paramsothy, S., Shamim, M. M. I., Borody, T. J., Leong, R. W., & Kaakoush, N. O. (2025). Bacterial taxonomic and functional changes following oral lyophilized donor fecal microbiota transplantation in patients with ulcerative colitis. mSystems, 10(10), e0099125. https://doi.org/10.1128/msystems.00991-25
Schmidt, T. S. B., Li, S. S., Maistrenko, O. M., Akanni, W., Coelho, L. P., Dolai, S., Fullam, A., Glazek, A. M., Hercog, R., Herrema, H., Jung, F., Kandels, S., Orakov, A., Thielemann, R., von Stetten, M., Van Rossum, T., Benes, V., Borody, T. J., de Vos, W. M., Ponsioen, C. Y., … Bork, P. (2022). Drivers and determinants of strain dynamics following fecal microbiota transplantation. Nature Medicine, 28(9), 1902–1912. https://doi.org/10.1038/s41591-022-01913-0
Shin, J. H., Tillotson, G., MacKenzie, T. N., Warren, C. A., Wexler, H. M., & Goldstein, E. J. C. (2024). Bacteroides and related species: The keystone taxa of the human gut microbiota. Anaerobe, 85, 102819. https://doi.org/10.1016/j.anaerobe.2024.102819
Singhal, R., Ghadvaje, G., Karra, N., Gadde, S. T., Chandra, P., Voruganti, B. K. T., Doddareddy, N. P., Iftikhar, S., & Patel, T. (2025). A narrative review on fecal microbiota transplantation routes in ulcerative colitis: Identifying the optimal approach across key parameters. Annals of Medicine and Surgery, 87(10), 6599–6611. https://doi.org/10.1097/MS9.0000000000003841
Steube, A., Stallhofer, J., & Stallmach, A. (2023). Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challenges. Frontiers in Gastroenterology, 2. https://doi.org/10.3389/fgstr.2023.1161610
Sunkara, T., Rawla, P., Ofosu, A., & Gaduputi, V. (2018). Fecal microbiota transplant—A new frontier in inflammatory bowel disease. Journal of Inflammation Research, 11, 321–328. https://doi.org/10.2147/JIR.S176190
Wilson, B. C., Vatanen, T., Cutfield, W. S., & O’Sullivan, J. M. (2019). The super-donor phenomenon in fecal microbiota transplantation. Frontiers in Cellular and Infection Microbiology, 9, 2. https://doi.org/10.3389/fcimb.2019.00002
Zhang, Y. J., Bousvaros, A., Docktor, M., Kaplan, A. L., Rufo, P. A., Leier, M., Weatherly, M., Zimmerman, L., Nguyen, L. T. T., Barton, B., Russell, G., Alm, E. J., & Kahn, S. A. (2024). Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after fecal microbiota transplant in inflammatory bowel disease. Scientific Reports, 14(1), 18188. https://doi.org/10.1038/s41598-024-68619-w
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Monika Kowalska, Anita Zięba, Michał Domin, Justyna Całka, Katarzyna Ścibisz, Karolina Ollik, Kamil Harenza, Mateusz Taranowicz, Olga Kowalczyk, Dominika Zdobylak
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
